Navigation Links
Bioheart Founder, Howard J. Leonhardt, Becomes Chairman of the Board of Directors
Date:3/17/2008

science that we believe will assist our efforts to commercialize our product candidates."

About MyoCell(R)

Bioheart's lead product candidate, MyoCell, is an innovative clinical cell therapy designed to populate regions of scar tissue within a patient's heart with living muscle tissue for the purpose of improving cardiac function in chronic heart failure patients. MyoCell uses adult stem cells that are precursors to muscle cells, or myoblasts, which are derived from the patient's own body. When injected into scar tissue within the heart wall, myoblasts have shown to be capable of engrafting in the damaged tissue and differentiating into mature muscle cells. The core technology used in MyoCell has been the subject of human clinical trials conducted over the last seven years and animal studies conducted over the last twenty years. Our most recent clinical trials of MyoCell include the SEISMIC Trial, a 40-patient Phase II clinical trial in various countries in Europe and the MYOHEART Trial, a completed 20-patient Phase I dose escalation trial in the United States. Final results of the MYOHEART Trial were announced in January 2008. The FDA recently cleared us to proceed with a multicenter Phase II/III trial for MyoCell in the United States, named the MARVEL Trial, which will enroll up to 330 patients.

About Bioheart, Inc.

Bioheart, Inc. is a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its lead product candidate, MyoCell, is an innovative clinical cell therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from the patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company's pipeline includes multiple product candidates for the treatment of heart damage, including Bioheart Acute Cell
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Quintiles Completes Previously Announced New Investor Partnership, Co-Led by Founder, Chairman and CEO Dennis Gillings, Bain Capital, TPG and 3i
2. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
3. VivoMetrics(R) Appoints Howard R. Baker as New President and Chief Executive Officer
4. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
5. REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide
6. Prof. Michel Klein Becomes Chief Scientific Officer at AMVAC
7. Haemonetics Becomes Preferred Provider of Plasma Collection Products to Octapharma Europe
8. BioStorage Technologies Becomes Green Powered through the Use of 100% Certified Renewable Energy
9. Pathway Medical Technologies Names Paul Buckman Chairman of the Board of Directors
10. Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
11. BioSeek Elects Roy Whitfield Executive Chairman of Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 2014 After the boom of the ... next beverage craze is going to be the stress ... can use Stress Relief energy pattern which can be ... of a beverage, including minerals, herbs and liquids. Stress ... that power into rapid recovery and helping to adapt ...
(Date:8/27/2014)... Ohio (PRWEB) August 27, 2014 ... from Cleveland's University School participated in ... Case Western Reserve University’s School of Medicine . ... students with an unparalleled professional experience in the ... School of Medicine faculty and students for both ...
(Date:8/26/2014)... 26, 2014 An analysis by Replikins, Ltd. ... Mers CoV virus strains has revealed extensive ... 2012.  This conservation and sharing of specific Replikin gene ... Blocker-Vaccine™ candidate, as it did for the H5N1 influenza ... which have been found to be effective (1,2). ...
(Date:8/26/2014)... , August 26, 2014 , ... NHS hospitals with surgery validation using its Stratasys Objet24 and ... Performing surgery on 3D printed models prior to operations reduces ... an effective aid for both patient and surgeon   ... ), a global leader of 3D printing and additive manufacturing ...
Breaking Biology Technology:Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4Students at Cleveland's University School Conduct Biomedical Research at Case Western Reserve University’s School of Medicine 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 2Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 3Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 4Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions 5
... Aperio , ... that improve patient care, and Definiens , the ... in which Aperio will market Definiens Tissue Studio™ ... digital pathology, on a worldwide, non-exclusive basis. ...
... 2011 SeraCare Life Sciences, Inc. (NASDAQ: ... products and services to facilitate the discovery, development and ... election of Joseph Nemmers and Kevin Hrusovsky to its ... has been appointed to the position of Chairman of ...
... OncoSec Medical Inc. (OTCBB: ONCS), a therapeutic oncology ... tumor cancers that have unmet medical needs, announced ... leadership team. Formed earlier this year, OncoSec expects ... tumor-destroying, tissue-sparing ElectroOncology therapies before the end of ...
Cached Biology Technology:Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis 2Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis 3Aperio Partners with Definiens to Market Definiens Tissue Studio for Advanced Image Analysis 4SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 2SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 3SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 4OncoSec Announces Leadership Team Appointments 2OncoSec Announces Leadership Team Appointments 3OncoSec Announces Leadership Team Appointments 4
(Date:8/27/2014)... a new skill is easier when it is related ... trained pianist might learn a new melody more easily ... Neural engineers from the Center for the Neural Basis ... Pittsburgh and Carnegie Mellon Universityhave discovered a fundamental constraint ... Published as the cover story in the Aug. 28, ...
(Date:8/27/2014)... grass species frequently found in forests has created a ... American toads, a new University of Georgia study has ... the U.S. in the early 1900s, is one of ... more than a dozen states in the past century, ... in forests, it can survive in widely diverse ecosystems ...
(Date:8/27/2014)... N.C. -- When we want to listen carefully to ... The second thing we do is stop moving altogether. ... sounds generated by our own movements. , This interplay ... in the brain. Indeed, indirect evidence has long suggested ... influences the auditory cortex, which gives rise to our ...
Breaking Biology News(10 mins):Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3More wolf spiders feasting on American toads due to invasive grass, UGA study shows 2More wolf spiders feasting on American toads due to invasive grass, UGA study shows 3Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3
... how two closely related proteins guide projections from nerve ... axons as they navigate the most miniscule and frenetic ... connections. The discovery, reported April 28 in the ... the "semaphorin" family of guidance cues are crucial for ...
... for coeliac disease has shown promising results for treating coeliac ... to move to Phase II trials within the next year. ... the safety, tolerability and bioactivity of the vaccine Nexvax2, which ... autoimmune disease caused by an immune reaction to the gluten ...
... of Global Change Biology Bioenergy outlines a ... issues surrounding the rapidly evolving race to develop biofuels. ... on Bioethics Working Party on Biofuels, and Scientific Adviser ... the Council,s proposed development of a comprehensive ethical standard ...
Cached Biology News:Johns Hopkins scientists reveal nerve cells' navigation system 2Johns Hopkins scientists reveal nerve cells' navigation system 3Celiac disease vaccine shows promising results in Phase I trial 2
... Lambda Protein Phosphatase ... Mn2+-dependent protein phosphatase with ... threonine and tyrosine residues. ... amino-acid product of the ...
... Innovative HL-2000 HybriLinker combines the benefits of a ... self-contained, space saving unit. , ... Laboratory allows crosslinking ,and hybridization at one location ... HL-2000 operate independently of each other , ...
... a wide variety of solvent vapors that can ... condensation flask (GCF400) allows for the collection of ... draining. Rapid cooling time minimizes waiting period., ... solvent changes , -50?C ...
... determined by Biuret Physical form: Solution in ... 7.6, 1 mM MgCl 2 and ... Definition: One unit will hydrolyze 1 μmole ... 9.8 at 37 C. • Concentration: ≥ ...
Biology Products: